TSE:2206Food
Ezaki Glico (TSE:2206) Could Be 46% Below Fair Value On Its Wellness Push
Viome Life Sciences and Ezaki Glico (TSE:2206) have launched mRNA HEALTH TRACKER®, billed as Japan’s first gut bacteria mRNA based personalized health service, tying the confectioner more directly to data driven wellness offerings.
Ezaki Glico’s tie up with Viome lands at a time when the 1 year total shareholder return is slightly down 1.2%, while the 3 year total shareholder return is up 30.1%. This suggests that longer term holders have seen stronger momentum than those focused on recent...